Amgen announces ‘positive’ Phase II lung cancer results for cancer drug with hard-to-reach target October 6, 2020 Auto Bot Amgen, BioPharma, biopharma nl, California, Non-Small Cell Lung Cancer, Sotorasib, Thousand Oaks 0 The company did not provide data, but said results for patients who received sotorasib at the 960mg dose were consistent with those seen in the Phase I portion of the Phase I/II study, which showed an overall response rate of 35.3%. ……